Kangmei Pharma reported 126.35 in PE Price to Earnings for its fiscal quarter ending in September of 2024.


Pe Change Date
Cspc Pharmaceutical 12.94 0.45 Mar/2025
Genomma Lab Internacional 10.52 1.07 Jun/2025
Hypermarcas 21.43 6.81 Jun/2025
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
IQVIA Holdings 20.69 1.92 Jun/2025
Jiangsu Hengrui 45.96 7.41 Jun/2025
Kangmei Pharma 126.35 9.9 Sep/2024
Moderna 27.22 14.51 Jun/2023
Organon & Co 2.58 1.6 Jun/2025
Revvity 40.39 5.61 Jun/2025
Sh Fosun Pharma 25.38 1.5 Jun/2025
Tectonic Therapeutic 4.01 0.63 Mar/2024
Viatris 22.25 216.55 Jun/2025
Wuxi Apptec 14.12 6.53 Jun/2025
Zz Pientze Pharmaceu 44.7 5.04 Jun/2025